The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
DDI has recently joined Twitter. For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: http://twitter.com/fda_drug_info.
We plan to provide updates when new information pertaining to drug products is posted to the FDA web site. DDI believes Twitter will be an invaluable resource to provide timely, accurate information to consumers, healthcare providers, and industry.
We recognize that new communication tools like Twitter derive much of their value from the two-way conversations that they enable, however DDI is only able to send out informational updates. To contact DDI, please email druginfo@fda.hhs.gov.
ABRIR AQUÍ para acceder al vínculo inter-activo (idioma inglés únicamente):
FDA Drug Information (FDA_Drug_Info) on Twitter
No hay comentarios:
Publicar un comentario